Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Testing a Smartphone App to Support a Mediterranean Diet and Strength Exercise (App-etite)

5 de noviembre de 2026 actualizado por: Liverpool John Moores University

App-etite for Change: A Four-Week Feasibility Randomised Controlled Trial of a Smartphone Application to Support Adherence to a Mediterranean-Style Diet and Resistance Exercise

Eating a Mediterranean-style diet and doing regular resistance training are both known to lower the risk of heart disease. However, most people find it hard to stick to these habits over time, and few smartphone apps support both diet and strength training together. This study tests a smartphone app called MedEx Tracker, which was developed by the research team. The app lets people record what they have eaten against a set of Mediterranean diet targets, record the weight and repetitions for each set of their resistance training, and see how they are doing through a progress screen. It also sends reminders during the day and suggests when to increase training weight. Healthy adults aged 18 to 55 will be randomly assigned to one of two groups. Both groups will be given the same Mediterranean diet targets and the same strength training programme. One group will receive this through the app; the other will receive it as a printed booklet. This means any difference between the groups should be due to the app itself rather than to different advice. Everyone will attend the laboratory before and after the four weeks for measurements and questionnaires. The main aim is to find out whether the app is usable and acceptable to participants, and whether it helps people stick to a Mediterranean-style diet and a resistance training programme. The findings will be used to decide whether the app is suitable for a larger future study.

Descripción general del estudio

Descripción detallada

This is a four-week, two-arm, parallel-group feasibility randomised controlled trial conducted at Liverpool John Moores University. Healthy adults aged 18 to 55 years who own a smartphone will be randomised in a 1:1 ratio to an application-supported intervention arm (APP) or a control arm (CON). Allocation will be generated by a staff member independent of the project using a computerised random number generator. Blinding of participants is not feasible given the nature of the intervention; statistical analysis will be performed by a blinded statistician.

All participants, irrespective of allocation, will receive the same printed booklet containing Mediterranean-style dietary serving targets with serving size definitions and a structured resistance exercise programme with written technique guidance and load progression criteria, and will be asked to follow these to the best of their ability throughout the four-week intervention period. Participants in the APP arm will additionally receive access to MedEx Tracker, a purpose-built cross-platform mobile application. The application supports structured daily and weekly dietary logging against the prescribed serving targets, set-level recording of resistance exercise including load and repetitions, automated load progression prompts, an inter-set rest timer, embedded exercise demonstration videos, a library of Mediterranean recipes, and a progress dashboard displaying computed daily and weekly dietary compliance. Automated reminders are delivered three times daily for diet and every alternate day for exercise. Both arms therefore receive an identical prescription, with access to the application, and the self-monitoring, progress feedback and automated reminders it provides, representing the only difference between groups.

All participants will attend the laboratory before and after the intervention period. Primary outcomes are adherence to a Mediterranean-style diet and a resistance exercise programme, and the usability, acceptability and engagement with the application. Dietary adherence will be assessed using the 14-item Mediterranean Diet Adherence Screener and resistance exercise adherence as weekly muscle-strengthening frequency using the long form of the Muscle-Strengthening Exercise Questionnaire. Usability and acceptability will be assessed using the Mobile App Usability Questionnaire and the user version of the Mobile Application Rating Scale, supplemented by a focus group at follow-up. Engagement will be derived from application-generated data, including frequency of access and completeness of dietary and resistance exercise records. Secondary outcomes include recruitment and retention rates, dietary intake derived from three-day food records, body mass and body composition.

The study is not powered to detect definitive between-group differences. Its purpose is to establish whether the application functions as an adherence support and tracking tool of sufficient quality to be used within a subsequent fully powered trial examining LDL aggregation susceptibility.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

30

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Alexandros M Amorginos, MSc
  • Número de teléfono: +447713180851
  • Correo electrónico: spsaamor@ljmu.ac.uk

Ubicaciones de estudio

    • Merseyside
      • Liverpool, Merseyside, Reino Unido, L3 3AF
        • Liverpool John Moores University
        • Contacto:

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 55 años (Adulto)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • own and use a smartphone
  • no contraindication to exercise on a pre-activity readiness questionnaire (PARQ)

Exclusion Criteria:

  • pregnant or nursing
  • presence of a dietary allergy or food intolerance
  • adherence to a restrictive diet (keto, carnivore, vegan, vegetarian etc)

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Prevención
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Application-supported

Participants receive Mediterranean-style dietary serving targets and a structured resistance exercise programme as a printed booklet, together with access to the MedEx Tracker mobile application, which provides self-monitoring, progress feedback, automated reminders and load progression prompts over four weeks.

MedEx Tracker is a purpose-built cross-platform smartphone application developed by the research team to support adherence to a Mediterranean-style diet and a resistance training programme. Participants record daily servings of six food groups and weekly servings of five further food groups against defined targets, with serving definitions available within the application. Resistance training is recorded at the level of individual sets, capturing the load lifted and repetitions completed, with demonstration videos, automated prompts to increase or reduce load based on previous performance, and an inter-set rest timer. A progress dashboard displays a computed daily and weekly dietary compliance percentage, sessions completed, and seven-day activity calendars. The application also provides a library of Mediterranean diet-aligned recipes and delivers automated reminders three times daily for diet and every alternate day for exercise.

A printed booklet containing Mediterranean-style dietary serving targets with accompanying serving size definitions, and the prescribed resistance exercises with written technique guidance and load progression criteria. Participants are asked to follow the programme to the best of their ability over the four-week study period.

Comparador activo: Printed booklet

Participants receive the same printed booklet containing Mediterranean-style dietary serving targets and a structured resistance exercise programme over four weeks. No application access, progress feedback or automated reminders are provided.

A printed booklet containing Mediterranean-style dietary serving targets with accompanying serving size definitions, and the prescribed resistance exercises with written technique guidance and load progression criteria. Participants are asked to follow the programme to the best of their ability over the four-week study period.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Mediterranean diet adherence
Periodo de tiempo: Baseline and week 4

Adherence measured using the 14-item Mediterranean Diet Adherence Screener (MEDAS). Total score ranges from 0 to 14, with higher scores indicating greater adherence

Baseline and week 4
Resistance exercise adherence
Periodo de tiempo: Baseline and week 4

Weekly muscle-strengthening exercise frequency, self-reported using the long form of the Muscle-Strengthening Exercise Questionnaire (MSEQ). Reported in days per week (minimum 0, maximum 7); higher values indicate more frequent muscle-strengthening exercise, i.e. greater adherence. This is a frequency count rather than a scale score; the MSEQ has no composite total score. Total weekly frequency is taken as the highest frequency reported across the four MSEQ exercise types.

Baseline and week 4
Application usability
Periodo de tiempo: Week 4 (end of intervention)

Usability assessed in the intervention group using the Mobile App Usability Questionnaire (MAUQ). Higher scores indicate better usability.

Week 4 (end of intervention)
Application quality and acceptability
Periodo de tiempo: Week 4 (end of intervention)

Assessed in the intervention group using the user version of the Mobile Application Rating Scale (uMARS), scored across engagement, functionality, aesthetics and information quality. Scoring is 1-5 (higher= better).

Week 4 (end of intervention)
Engagement with the application
Periodo de tiempo: Weeks 1-4, recorded continuously by the application

Frequency of application access and completeness of dietary and resistance training records, derived from application-generated data in the intervention group.

Weeks 1-4, recorded continuously by the application

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Dietary intake
Periodo de tiempo: Baseline and week 4

Energy and macronutrient intake derived from three-day food records.

Baseline and week 4
Body mass
Periodo de tiempo: Baseline and week 4

In kg using calibrated scales

Baseline and week 4
Body composition
Periodo de tiempo: Baseline and week 4

Fat mass and fat-free mass assessed by bioelectrical impedance analysis

Baseline and week 4
Recruitment rate
Periodo de tiempo: From the start of recruitment to randomisation of the final participant (up to approximately 4 months)

Number of participants randomised per month of recruitment. Also reported:

  • number screened
  • proportion of those screened who are eligible
  • proportion of eligible people who consent and are randomised
From the start of recruitment to randomisation of the final participant (up to approximately 4 months)
Retention rate
Periodo de tiempo: Baseline to week 4 (end of intervention)

Proportion of randomised participants who attend the week-4 follow-up visit, reported overall and by arm, with reasons for withdrawal where given.

Baseline to week 4 (end of intervention)

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Director de estudio: Richard P Kirwan, PhD, Liverpool John Moores University

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de noviembre de 2026

Finalización primaria (Estimado)

1 de febrero de 2027

Finalización del estudio (Estimado)

1 de marzo de 2027

Fechas de registro del estudio

Enviado por primera vez

9 de octubre de 2026

Primero enviado que cumplió con los criterios de control de calidad

13 de octubre de 2026

Publicado por primera vez (Actual)

21 de octubre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

6 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

5 de noviembre de 2026

Última verificación

1 de octubre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

Individual participant data will not be made publicly available. The small sample size and single-site recruitment mean that participants could potentially be identified from combinations of demographic and anthropometric variables. Requests for data access will be considered on an individual basis by the corresponding author, subject to approval by the Liverpool John Moores University Research Ethics Committee and completion of a data sharing agreement.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir